Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CTKB | US
0.08
1.77%
Healthcare
Medical Devices
30/06/2024
07/04/2026
4.60
4.51
4.63
4.43
Cytek Biosciences Inc. a cell analysis solutions company provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits including cFluor reagents which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells monocytes dendritic cells and basophils. In addition it offers automated micro-sampling system and automated sample loader system which are automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies academic research centers and clinical research organizations. It distributes its products through direct sales force and support organizations in North America Europe China and the Asia-Pacific region; and through distributors or sales agents in European Latin American the Middle Eastern and the Asia-Pacific countries. The company was formerly known as Cytoville Inc. and changed its name to Cytek Biosciences Inc. in August 2015. Cytek Biosciences Inc. was founded in 1992 and is headquartered in Fremont California.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
37.0%1 month
43.0%3 months
44.1%6 months
58.1%-
370.37
1.74
0.09
0.07
-133.96
2.09
-
-17.41M
604.93M
604.93M
-
-18.29
65.80
-6.20
-4.32
6.09
4.19
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.56
Range1M
0.80
Range3M
2.09
Rel. volume
0.68
Price X volume
2.31M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Tactile Systems Technology Inc | TCMD | Medical Devices | 24.05 | 576.40M | -2.12% | 10.39 | 23.72% |
| Bioventus Inc. | BVS | Medical Devices | 8.84 | 576.25M | -2.00% | n/a | 261.56% |
| MiMedx Group Inc | MDXG | Medical Devices | 3.86 | 566.68M | -0.52% | 10.21 | 11.46% |
| SI-BONE Inc | SIBN | Medical Devices | 13.17 | 549.11M | -0.30% | n/a | 24.28% |
| Embecta Corp | EMBC | Medical Instruments & Supplies | 8.83 | 509.51M | -1.12% | 11.37 | -216.41% |
| Orthofix International N.V | OFIX | Medical Devices | 11.71 | 447.03M | -0.51% | n/a | 28.63% |
| Neuropace Inc. Common Stock | NPCE | Medical Devices | 14.51 | 423.65M | -0.62% | n/a | 745.17% |
| AngioDynamics Inc | ANGO | Medical Instruments & Supplies | 9.7 | 394.15M | -1.42% | n/a | 2.44% |
| OrthoPediatrics Corp | KIDS | Medical Devices | 15.76 | 381.62M | -1.13% | n/a | 3.67% |
| Common Stock | VMD | Medical Devices | 9.61 | 373.12M | -1.54% | 39.96 | 10.44% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Latham Group Inc. | SWIM | Building Products & Equipment | 5.17 | 597.53M | -2.08% | 65.18 | 77.00% |
| Ennis Inc | EBF | Building Products & Equipment | 21.72 | 564.80M | -0.23% | 13.28 | 2.28% |
| The Real Brokerage Inc. Common Shares | REAX | Real Estate Services | 2.45 | 484.50M | -3.16% | n/a | 0.00% |
| FRP Holdings Inc | FRPH | Real Estate Services | 22.13 | 421.14M | -0.23% | 75.50 | 42.65% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 2.84 | 272.07M | -1.73% | n/a | 174.23% |
| The RMR Group Inc | RMR | Real Estate Services | 15.81 | 264.42M | -0.50% | 16.64 | 14.14% |
| Comstock Holding Companies Inc | CHCI | Real Estate Services | 18.85 | 185.90M | -2.43% | 14.10 | 17.12% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 16.33 | 182.21M | -1.27% | 15.61 | -621.78% |
| RE/MAX Holdings Inc | RMAX | Real Estate Services | 5.74 | 180.33M | -1.20% | n/a | 114.28% |
| Douglas Elliman Inc. | DOUG | Real Estate Services | 1.6 | 146.93M | -4.19% | n/a | 62.82% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -133.96 | 46.09 | Cheaper |
| Ent. to Revenue | 2.09 | 14.34 | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 1.74 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 44.07 | 64.12 | Lower Risk |
| Debt to Equity | 0.09 | -145.53 | Expensive |
| Debt to Assets | 0.07 | 0.35 | Cheaper |
| Market Cap | 604.93M | 9.70B | Emerging |